BROADWOOD CAPITAL INC Lineage Cell Therapeutics, Inc. Transaction History

BROADWOOD CAPITAL INC portfolio value:

$39.47M
portfolio value

BROADWOOD CAPITAL INC quarter portfolio value change:

-28.48%
quarter

Lineage Cell Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -15.72M $1.13 34.93M
Q2 2022 share 0.00% 0 shares 1.39M $1.58 34.93M
Q1 2022 share Increase +2.74% 930.10K shares -29.51M $1.54 34.93M
Q4 2021 share 0.00% 0 shares -2.38M $2.5 34.00M
Q3 2021 share 0.00% 0 shares -11.22M $2.52 34.00M
Q2 2021 share 0.00% 0 shares 17.00M $2.85 34.00M
Q1 2021 share 0.00% 0 shares 20.06M $2.35 34.00M
Q4 2020 share 0.00% 0 shares 28M $1.76 34.00M
Q3 2020 share 0.00% 0 shares 2.26M $0.94 34.00M
Q2 2020 share 0.00% 0 shares 1.42M $0.87 34.00M
Q1 2020 share 0.00% 0 shares -2.10M $0.83 34.00M
Q4 2019 share 0.00% 0 shares -3.06M $0.89 34.00M
Q3 2019 share Increase 0.00% 34.00M shares 33.32M $0.98 34.00M